High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Whether high-dose dexamethasone has long-term efficacy and safety in previously untreated patients with immune thrombocytopenia is unclear. We did a systematic review and a meta-analysis of randomised trials to establish the effect of high-dose dexamethasone compared with prednisone for long-term platelet count response.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Lancet Haematol

Title: The Lancet. Haematology

Publisher: Elsevier BV

ISSN (Electronic): 2352-3026

ISSN (Print): 2352-3026

Publication date (Electronic): Oct 2016

Volume: 3

Issue: 10

Affiliations

[1 ] Department of Medicine, Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.

[2 ] McMaster Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.

[3 ] McMaster Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada; Department of Medicine, Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; Canadian Blood Services, Hamilton, ON, Canada. Electronic address: arnold@mcmaster.ca.

Article

Publisher Item ID: S2352-3026(16)30109-0

DOI: 10.1016/S2352-3026(16)30109-0

PubMed ID: 27658982

SO-VID: 2216b2bf-41a2-4c00-a471-a85639b9c347

History

Data availability:

Comments

Comment on this article

scite_

Cited by 54

See all cited by

- Version 1